KALETRA
KALETRA
Approved
DIN Number
02285533
Drug Class
Human
Market Date
Sep 8, 2006
Company
HC
Abbvie Corporation
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02285533
AIG Number0243421003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
J05AR10 LOPINAVIR AND RITONAVIR
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification08:18.08.08
Health Canada Classification
ACTIVE INGREDIENTS (2)
LOPINAVIRActive
Strength: 200 MG
Monograph: LOPINAVIR
RITONAVIRActive
Strength: 50 MG
Monograph: RITONAVIR